LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | PLX-4720 | 1.11 | uM | LJP5 | 3 | K03 | 72 | hr | 1235 | 4834 | 4513 | 1.0710 | 1.0977 |
| MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 1 | F21 | 72 | hr | 1235 | 2820 | 4513 | 0.6248 | 0.4833 |
| MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 2 | F21 | 72 | hr | 1235 | 2637 | 4513 | 0.5842 | 0.4275 |
| MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 3 | F21 | 72 | hr | 1235 | 2841 | 4513 | 0.6294 | 0.4897 |
| MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 1 | O21 | 72 | hr | 1235 | 1174 | 4513 | 0.2601 | -0.0189 |
| MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 2 | O21 | 72 | hr | 1235 | 1247 | 4513 | 0.2763 | 0.0034 |
| MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 3 | O21 | 72 | hr | 1235 | 1212 | 4513 | 0.2685 | -0.0073 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 1 | K09 | 72 | hr | 1235 | 915 | 4513 | 0.2027 | -0.0979 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 2 | K09 | 72 | hr | 1235 | 989 | 4513 | 0.2191 | -0.0753 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 3 | K09 | 72 | hr | 1235 | 1108 | 4513 | 0.2455 | -0.0390 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 1 | K09 | 72 | hr | 1235 | 1098 | 4513 | 0.2433 | -0.0421 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 2 | K09 | 72 | hr | 1235 | 1374 | 4513 | 0.3044 | 0.0421 |
| MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 3 | K09 | 72 | hr | 1235 | 1068 | 4513 | 0.2366 | -0.0512 |
| MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 1 | J03 | 72 | hr | 1235 | 3745 | 4513 | 0.8297 | 0.7655 |
| MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 2 | J03 | 72 | hr | 1235 | 4032 | 4513 | 0.8933 | 0.8531 |
| MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 3 | J03 | 72 | hr | 1235 | 4573 | 4513 | 1.0132 | 1.0181 |
| MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 1 | O15 | 72 | hr | 1235 | 3792 | 4513 | 0.8401 | 0.7798 |
| MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 2 | O15 | 72 | hr | 1235 | 4052 | 4513 | 0.8977 | 0.8592 |
| MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 3 | O15 | 72 | hr | 1235 | 4515 | 4513 | 1.0003 | 1.0004 |
| MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 1 | G09 | 72 | hr | 1235 | 4927 | 4513 | 1.0916 | 1.1261 |
| MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 2 | G09 | 72 | hr | 1235 | 5089 | 4513 | 1.1275 | 1.1755 |
| MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 3 | G09 | 72 | hr | 1235 | 5034 | 4513 | 1.1153 | 1.1588 |
| MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 1 | D09 | 72 | hr | 1235 | 2706 | 4513 | 0.5995 | 0.4485 |
| MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 2 | D09 | 72 | hr | 1235 | 2917 | 4513 | 0.6463 | 0.5129 |
| MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 3 | D09 | 72 | hr | 1235 | 2882 | 4513 | 0.6385 | 0.5022 |